Michael Thomas Henderson, Director: Spyre Therapeutics SYRE Planned sale · Filed 05/08

Trade details

Type: Planned sale notice
Stock: Spyre Therapeutics SYRE
Person: Michael Thomas HendersonDirector
Planned sale date: 26/05/08
Filed: 26/05/08

$5.8M to be sold

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 04/08~06/07

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
Michael Thomas HendersonDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10

Michael Thomas Henderson, Director — plans to sell 80,000 sh of Spyre Therapeutics SYRE · $5.8M · around 05/08 · 10b5-1 plan | Whalegun